Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting ; day:1 ; month:8 ; year:2020 ; pages:1-8
Breast cancer research and treatment ; (1.8.2020), 1-8
- Creator
-
Joona, Therse Björkin
Digkas, Evangelos
Wennstig, Anna-Karin
Nyström, Karin
Nearchou, Andreas
Nilsson, Cecilia
Pauksens, Karlis
Valachis, Antonis
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-020-05815-y
- URN
-
urn:nbn:de:101:1-2020092712120947392166
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Joona, Therse Björkin
- Digkas, Evangelos
- Wennstig, Anna-Karin
- Nyström, Karin
- Nearchou, Andreas
- Nilsson, Cecilia
- Pauksens, Karlis
- Valachis, Antonis
- SpringerLink (Online service)
Other Objects (12)
Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
The antibody response in the bovine mammary gland is influenced by the adjuvant and the site of subcutaneous vaccination
Development of a subcutaneous malaria whole-parasite vaccination
Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza
Influenza vaccination in pediatric age
Psychological determinants of influenza vaccination
Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
The antibody response in the bovine mammary gland is influenced by the adjuvant and the site of subcutaneous vaccination
Development of a subcutaneous malaria whole-parasite vaccination
Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza
Influenza vaccination in pediatric age
Psychological determinants of influenza vaccination
Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
The antibody response in the bovine mammary gland is influenced by the adjuvant and the site of subcutaneous vaccination
Development of a subcutaneous malaria whole-parasite vaccination
Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza
Influenza vaccination in pediatric age
Psychological determinants of influenza vaccination